Treatment Options for Chronic Urticaria

Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age13-60
SponsorSheikh Zayed Medical College

About this trial

chronic urticaria is one of the most common dermatological disease affecting many people, exploring most treatment options for its treatment is need of an hour.

Our study aim to compare the efficacy of Autologous Serum Therapy (AST) with levocetirizine in Chronic Urticaria patients

Eligibility criteria

Qualifiers

Age: 13-60 years

Gender: Both male and female

Patients having urticaria for more than 6 weeks diagnosed clinically

Disqualifiers

Pregnancy and lactating females

Patients who are immunosuppressed either due to medication or disease.

Patients suffering from chronic diseases i-e chronic liver disease, chronic kidney disease.

Patients taking steroids in last 2 weeks.

Trial design

Treatments tested in this trial

  • Autologous serum therapy
  • Oral levocetirizine

Treatment groups

72 Participants
are divided into 2 treatment groups

Sponsors and collaborators